News

Chevron cut at BNP Paribas on more cautious oil price outlook, worries over Hess deal
Chevron downgraded at BNP Paribas Exane, which takes a more cautious view on the prospects for oil prices over the next 12-18 ...
GSK initiated with a Neutral at BNP Paribas Exane
BNP Paribas Exane analyst Peter Verdult initiated coverage of GSK (GSK) with a Neutral rating and $35.25 price target Stay Ahead of the Market: ...
BNP Paribas Exane downgrades Chevron on cautious oil view
BNP Paribas Exane downgraded Chevron (CVX) to Neutral from Outperform with a $140 price target The firm cites its more cautious view on oil ...